Peng Ning
Research Subjects
Research Interests
Peng Ning has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Hui Chang
Baoji High-tech Hospital, Baoji, Shaanxi, China
1 shared publication - Meilin Weng
Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
1 shared publication - Qingyao Zhong
Zhongshan Hospital Fudan University, Shanghai, China
1 shared publication - Xingyao Yan
The 987th Hospital of the Joint Logistics Support Force, Baoji, China
1 shared publication - Yuexin Liu
Department of Medical Neuroscience School of Medicine Southern University of Science and Technology Shenzhen China
1 shared publication
Latest Publications
- Open Access
Global burden of brain and central nervous system cancer among people aged 20–64 years, 1992–2021 and projections to 2050: a population-based study
Objectives To estimate the burden, trends, and inequalities of brain and central nervous system cancer (CNS cancer) among adults at global, regional and national level from 1992 to 2021. Design Population-based study. Population Adults aged 20–64 years from 21 regions and 204 countries and territories (Global Burden of Disease and Risk Factors Study 2021) from 1992 to 2021. Main outcome measures Our primary outcomes comprised age-standardised prevalence, incidence, mortality and disability-adjusted life-years (DALYs) for CNS cancers. The analytical framework incorporated temporal trend analysis through annual percentage change (APC) and average APC (AAPC) metrics, complemented by Bayesian age-period-cohort modelling to assess demographic influences. We employed predictive modelling with decomposition techniques to evaluate contributions from age structure shifts, population dynamics and risk factor modifications, while spatiotemporal Gaussian process regression enabled robust smoothing and trend estimation across continuous time-space dimensions. The study specifically applied frontier analysis methodologies to examine epidemiological patterns of prevalence, incidence, mortality and DALYs within the 20–64 years adult population. Results From 1992 to 2021, the global age-standardised prevalence (AAPC 1.04 (95% CI 0.91 to 1.18); pConclusions Significant inequalities exist in age-standardised prevalence, incidence, DALYs and mortality of CNS cancer among countries with varying sociodemographic indices. These disparities highlight the urgent need for targeted clinical guidelines and equitable distribution of global health resources.
Open AccessGlobal burden of brain and central nervous system cancer among people aged 20–64 years, 1992–2021 and projections to 2050: a population-based study
Objectives To estimate the burden, trends, and inequalities of brain and central nervous system cancer (CNS cancer) among adults at global, regional and national level from 1992 to 2021. Design Population-based study. Population Adults aged 20–64 years from 21 regions and 204 countries and territories (Global Burden of Disease and Risk Factors Study 2021) from 1992 to 2021. Main outcome measures Our primary outcomes comprised age-standardised prevalence, incidence, mortality and disability-adjusted life-years (DALYs) for CNS cancers. The analytical framework incorporated temporal trend analysis through annual percentage change (APC) and average APC (AAPC) metrics, complemented by Bayesian age-period-cohort modelling to assess demographic influences. We employed predictive modelling with decomposition techniques to evaluate contributions from age structure shifts, population dynamics and risk factor modifications, while spatiotemporal Gaussian process regression enabled robust smoothing and trend estimation across continuous time-space dimensions. The study specifically applied frontier analysis methodologies to examine epidemiological patterns of prevalence, incidence, mortality and DALYs within the 20–64 years adult population. Results From 1992 to 2021, the global age-standardised prevalence (AAPC 1.04 (95% CI 0.91 to 1.18); pConclusions Significant inequalities exist in age-standardised prevalence, incidence, DALYs and mortality of CNS cancer among countries with varying sociodemographic indices. These disparities highlight the urgent need for targeted clinical guidelines and equitable distribution of global health resources.